tiprankstipranks
Trending News
More News >
SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market

SynAct Pharma AB (8F8) Financial Statements

Compare
0 Followers

SynAct Pharma AB Financial Overview

SynAct Pharma AB's market cap is currently €75.55M. The company's EPS TTM is €-0.183; its P/E ratio is ―; SynAct Pharma AB is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr -778.00Kkr -1.06Mkr -88.00Kkr 0.00kr -338.51K
Operating Incomekr -224.50Mkr -105.70Mkr -76.70Mkr -31.29Mkr -24.80M
EBITDAkr -222.70Mkr -105.71Mkr -76.62Mkr -30.90Mkr -25.01M
Net Incomekr -215.81Mkr -99.20Mkr -69.30Mkr -26.55Mkr -23.96M
Balance Sheet
Cash & Short-Term Investmentskr 62.40Mkr 108.25Mkr 24.00Mkr 14.55Mkr 3.56M
Total Assetskr 228.02Mkr 142.60Mkr 38.37Mkr 21.59Mkr 23.81M
Total Debtkr 637.00Kkr 2.06Mkr 3.09Mkr 0.00kr 0.00
Net Debtkr -61.76Mkr -106.18Mkr -20.91Mkr -14.55Mkr -3.56M
Total Liabilitieskr 51.83Mkr 16.08Mkr 17.50Mkr 5.72Mkr 10.31M
Stockholders' Equitykr 176.19Mkr 126.52Mkr 20.87Mkr 15.87Mkr 13.50M
Cash Flow
Free Cash Flowkr -100.18Mkr -117.56Mkr -65.00Mkr -33.24Mkr -16.62M
Operating Cash Flowkr -100.18Mkr -117.56Mkr -65.00Mkr -33.24Mkr -16.12M
Investing Cash Flowkr 370.00Kkr 27.00Kkr -6.00Kkr -93.00Kkr -499.00K
Financing Cash Flowkr 53.98Mkr 200.71Mkr 74.32Mkr 44.72Mkr 13.00M
Currency in SEK

SynAct Pharma AB Earnings and Revenue History

SynAct Pharma AB Debt to Assets

SynAct Pharma AB Cash Flow

SynAct Pharma AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis